Mona Alshahawey
Overview
Explore the profile of Mona Alshahawey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alshahawey M, Jafari E, Smith S, McDonough C
J Am Med Inform Assoc
. 2024 Aug;
31(12):2899-2907.
PMID: 39181122
Background: Hypertension (HTN) remains a significant public health concern and the primary modifiable risk factor for cardiovascular disease, which is the leading cause of death in the United States. We...
2.
Salgado T, Birari P, Alshahawey M, Zacholski E, Mackler E, Buffington T, et al.
Support Care Cancer
. 2024 Aug;
32(8):563.
PMID: 39088060
Purpose: Neither the United States nor the European oncology guidelines include details for appropriate management of hyperglycemia in cancer patients. The aim was to identify fasting and random blood glucose...
3.
Alshahawey M
Med Hypotheses
. 2021 Feb;
149:110531.
PMID: 33607405
It's since December 2019 that Corona virus disease (COVID-19) has emerged to be the global issue of concern. A "pandemic"; this is what WHO has declared about the COVID-19 outbreak...
4.
Alshahawey M, El Borolossy R, Wakeel L, Elsaid T, Sabri N
Nutr Metab Cardiovasc Dis
. 2021 Feb;
31(2):626-633.
PMID: 33594986
Background And Aim: Vascular calcification is an independent risk factor for cardiovascular diseases and all-cause mortality in end stage renal disease, and particularly in hemodialysis patients. Vitamin D deficiency has...
5.
Alshahawey M, Raslan M, Sabri N
Curr Res Transl Med
. 2020 Sep;
68(4):149-150.
PMID: 32917573
No abstract available.
6.
Alshahawey M
Int J Vitam Nutr Res
. 2020 Jul;
91(5-6):383-384.
PMID: 32674673
No abstract available.
7.
Alshahawey M, Shaheen S, Elsaid T, Sabri N
Int Urol Nephrol
. 2019 Aug;
51(9):1649-1657.
PMID: 31368057
Purpose: Oxidative stress, which is most likely a key mediator in the development of cardiovascular disease, is implicated in the progression and deterioration of chronic kidney disease. Patients on hemodialysis...
8.
Alshahawey M, Shahin S, Elsaid T, Sabri N
Am J Nephrol
. 2017 May;
45(5):452-459.
PMID: 28463849
Background: Endothelial dysfunction is an important risk factor for cardiovascular diseases to occur in end-stage renal disease patients. Febuxostat, being a novel xanthine oxidase inhibitor, is apparently having a beneficial...